Belviq
Editor-In-Chief: Prab R. Tumpati M.D.. Founder, WikiMD and W8MD Weight Loss, Sleep and MedSpa Centers. Dr. Tumpati is board certified physician practicing sleep medicine, obesity medicine, aesthetic medicine and internal medicine. Dr. Tumpati’s passion is prevention rather than cure. As a physician with fellowship training in Obesity Medicine, Dr. Tumpati has a unique approach to wellness, weight loss, aesthetics with a focus on prevention rather than cure. Dr. Tumpati believes in educating the public on the true science and art of medicine, nutrition, wellness and beauty.
|
WikiMD Resources for Belviq |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Belviq at Clinical Trials.gov Clinical Trials on Belviq at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Belviq
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Belviq Risk calculators and risk factors for Belviq
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Belviq(Lorcaserin) is a relatively new weight loss medication that was approved by the United States Food and Drug Administration (USFDA) in June of 2012 as an a long term treatment for obesity or overweight status. The other new weight loss medication, Qsymia, was also approved by the USFDA around the same time in June of 2012.
Background
As the United States and the rest of the world fights an epidemic of obesity or being overweight, there has long been a need for medications that curb the appetite, stimulate metabolism and assist in patients efforts at losing weight under the supervision of a weight loss physician. See the main article diet pills.
Who is a candidate for Belviq?
You may be talk to your doctor about Belviq or Qsymia if you:
- 18 years or older
- Have a Body mass index of 30 or more
- Have a Body mass index of 27 or more and have one or more medical problems related to overweight status.
How Does Belviq Work?
Belviq(lorcaserin) works by activating a part of the mind that controls hunger called appetite center.
How is Belviq taken?
Belviq is a 10 mg tablet taken twice a day.
Clinical trials of Belviq
- Belviq was investigated or studied in three clinical trials that continued from 52 to 104 weeks with nearly 8,000 obese and overweight patients.
Amount of weight loss with Belviq
The mean weight decrease for patients taking Belviq ranged from 3 to 3.7 percent over those taking a placebo.
- in patients without type 2 diabetes, about 47 per-cent of patients lost at least 5 percent of their weight compared with 23 per hundred of patients treated with placebo.
Belviq should be ceased or stopped if a patient falls short or fails to lose 5 per hundred of their weight after 12 weeks of treatment,as it is improbable that continued treatment will be successful.
Locations for Belviq
- W8MD medical weight loss centers locations do offer Belviq, Qsymia and other weight loss medications when medically appropriate.
Also see
Also see
Obesity | Diet | Nutrition | Wellness | Encyclopedia of obesity | Weight loss articles | Encyclopedia of weight loss
External links
Sponsors
 |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
Quick links: Medicine Portal | Encyclopedia | Gray's Anatomy | Topics | Diseases | Drugs | Wellness | Obesity | Metabolic syndrome | Weight loss*
Disclaimer: The entire contents of WIKIMD.ORG are for informational purposes only and do not render medical advice or professional services. If you have a medical emergency, you should CALL 911 immediately! Given the nature of the wiki, the information provided may not be accurate, misleading and or incorrect. Use the information on this wiki at your own risk! See full Disclaimer.
Link to this page: <a href="http://www.wikimd.org/wiki/Belviq">Belviq</a>
- Individual results may vary for weight loss from our sponsors.
